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In 2015, as we review progress towards Millennium Devel-
opment Goals (MDGs), despite significant progress in
reduction of mortality, we still have unacceptably high
numbers of maternal and newborn deaths globally. Efforts
over the past decade to reduce adverse outcomes for preg-
nant women and newborns have been directed at increas-
ing skilled birth attendance.1,2 This has resulted in higher
rates of births in health facilities in all regions.3 The pro-
portion of deliveries reportedly attended by skilled health
personnel in developing countries rose from 56% in 1990
to 68% in 2012.4 With increasing utilisation of health ser-
vices, a higher proportion of avoidable maternal and peri-
natal mortality and morbidity have moved to health
facilities. In this context, poor quality of care (QoC) in
many facilities becomes a paramount roadblock in our
quest to end preventable mortality and morbidity.
QoC during childbirth in health facilities reflects the
available physical infrastructure, supplies, management, and
human resources with the knowledge, skills and capacity to
deal with pregnancy and childbirth—normal physiological,
social and cultural processes, but prone to complications
that may require prompt life-saving interventions. Research
shows that it is necessary to go beyond maximising cover-
age of essential interventions to accelerate reductions in
maternal and perinatal mortality and severe morbidity.5
Moreover, there is a complex interplay of experiences of
mistreatment and lack of support that impact women’s
childbirth experiences and outcomes.6
Moving beyond 2015, the World Health Organization
(WHO) envisions a world where ‘every pregnant woman
and newborn receives quality care throughout pregnancy,
childbirth and the postnatal period.’ This vision is in align-
ment with two complementary global action agendas con-
ceptualised by WHO and partners in 2013–2014
—’Strategies toward Ending Preventable Maternal Mortality
(EPMM)’ and ‘Every Newborn Action Plan (ENAP)’.7,8 It
is articulated at a critical time when the global community
is developing the new Global Strategy for Women’s, Chil-
dren’s and Adolescents’ Health (2016–2030) for the post-
2015 Sustainable Development Goal era.9
Although indirect causes of maternal death are increas-
ing (27.5% of maternal deaths), globally, over 70% of
maternal deaths occur as a result of complications of preg-
nancy and childbirth such as haemorrhage, hypertensive
disorders, sepsis and abortion.10 Complications of preterm
birth, birth asphyxia, intrapartum-related neonatal death
and neonatal infections together account for more than
85% of newborn mortality.11 Therefore, the time of child-
birth and the period immediately after birth are particu-
larly critical for maternal, fetal and neonatal survival and
well-being. Effective care to prevent and manage complica-
tions during this critical period is likely to have a signifi-
cant impact on reducing maternal deaths, stillbirths and
early neonatal deaths—a triple return on investment.12
Within this critical period, quality of care improvement
efforts would target essential maternal and newborn care
and additional care for management of complications that
could achieve the highest impact on maternal, fetal and
newborn survival and well-being. Based on the current
evidence on burden and impact, the following specific
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Commentary
thematic areas have been identified as high priority for this
vision:10–12
1 Essential childbirth care including labour monitoring
and action and essential newborn care at birth and dur-
ing the first week;
2 Management of pre-eclampsia, eclampsia and its compli-
cations;
3 Management of postpartum haemorrhage;
4 Management of difficult labour by enabling safe and
appropriate use of medical technologies during childbirth;
5 Newborn resuscitation;
6 Management of preterm labour, birth and appropriate
care for preterm and small babies;
7 Management of maternal and newborn infections.
To end preventable maternal and newborn morbidity
and mortality, every pregnant woman and newborn need
skilled care at birth with evidence-based practices delivered
in a humane, supportive environment. Good quality of care
requires appropriate use of effective clinical and non-clini-
cal interventions, strengthened health infrastructure and
optimum skills and attitude of health providers, resulting
in improved health outcomes and positive experience of
women and providers. Moreover, quality of care is consid-
ered a key component of the right to health, and the route
to equity and dignity for women and children.13
So, what is quality of care? To underpin this vision, we
need a common understanding of what it means. This
WHO vision defines quality of care as ‘the extent to which
health care services provided to individuals and patient
populations improve desired health outcomes. In order to
achieve this, health care needs to be safe, effective, timely,
efficient, equitable, and people-centred.’14,15 Operational
definitions for the characteristics of quality of care are
defined in Box 1.
Quality of care is a multi-dimensional concept. There-
fore, a framework with important domains of measurement
and pathways to achieve the desired health outcomes is
required to identify the action points to improve the quality
of care. Since the Donabedian model of quality of care for
health facilities was proposed in 1988, WHO and others
have developed strategic thinking to operationalise key char-
acteristics of QoC, using different elements from the provi-
sion of care as well as the experience of care, integral to
maternal and newborn care provided in the facilities.15–19
WHO has also advanced health systems thinking by identi-
fying six building blocks—service delivery; health workforce;
information, medical products, vaccines and technologies;
financing, and leadership/governance—creating a structure
from where health systems analysis and intervention points
can be established.20
Building on these developments, the framework
(Figure 1) conceptualises QoC for maternal and newborn
health by identifying domains of QoC which should be
targeted to assess, improve and monitor care within the
context of the health system as the foundation. Health
systems create the structure which enables access to quality
care and allows for the process of care to occur along two
important and inter-linked dimensions of provision and
experience of care.
Based on this framework, QoC for pregnant women and
newborns in facilities requires competent and motivated
human resources and the availability of essential physical
resources. Also, evidence-based practices for routine and
emergency care, actionable information systems where
record keeping enables review and audit mechanisms, and
functional referral systems between levels of care should be
in place. Experience of care includes firstly effective com-
munication—a woman (or her family if required) should
feel that she understands what is happening, what to expect
and knows her rights. Secondly, she should receive care
with respect and dignity. Thirdly, she should have access to
the social and emotional support of her choice.
Improved QoC increases the likelihood of desired indi-
vidual and facility-level outcomes—health outcomes, cover-
age of key practices and people-centred outcomes—with a
focus on the identified high priority thematic areas
described above. Although our framework focuses on the
care provided in the facilities, it should be noted that com-
munities and service users have a critical role in identifying
their own needs and preferences, and in managing their
own health. Perspectives of women, their families and com-
munities, on the quality of maternity care services influence
decisions to seek care and are essential components for cre-
ating a demand for and access to quality maternal and
newborn services.6 Community engagement, therefore, is
an important aspect to be considered.
A number of strategies that guide implementation efforts
to improve QoC have been proposed. Many of these pri-
marily focus on adapting interventions and working to
Box 1 Operational definitions for the characteristics
of QoC definition14,15
 Safe—delivering health care which minimises risks and harm
to service users, including avoiding preventable injuries and
reducing medical errors
 Effective—providing services based on scientific knowledge
and evidence-based guidelines
 Timely—reducing delays in providing/receiving health care
 Efficient—delivering health care in a manner which maximis-
es resource use and avoids wastage
 Equitable—delivering health care which does not vary in
quality because of personal characteristics such as gender, race,
ethnicity, geographical location or socioeconomic status
 People-centred—providing care which takes into account the
preferences and aspirations of individual service users and the
cultures of their communities
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overcome barriers to adaptation and implementation.21
However, these strategies do not always address the funda-
mental issue of achieving a balance between conformity to
the evidence-based practices and accommodating contex-
tual differences, which underlies successful implementation.
Moreover, without the appropriate tools and materials
available in a user-friendly format, health systems are less
likely to implement an evidence-based intervention, and,
even if implemented, they may be suboptimal.
In this vision, WHO will use a QoC improvement strat-
egy, an adaptation of the ‘Plan-Do-Study Act’ (PDSA) cycle
model22 based on evidence synthesis, best practice and
experience. This strategy provides a roadmap for continu-
ous quality improvement. It starts by setting aims and
building teams to achieve desired outcomes through imple-
mentation of evidence-based change packages (individual,
multi-faceted and/or complex interventions depending on
the context and the needs). It also incorporates capacity
strengthening and other strategies to maximise the chances
for sustaining the implementation.23,24 In this context,
quality improvement should achieve the standards set for
both provision and experience of care.
Consolidating the framework and the improvement
strategy described above, WHO will develop a comprehen-
sive approach to provide guidance to global and national
stakeholders to realise this vision. Figure 2 depicts how the
WHO approach consolidates the QoC framework and
improvement strategy, and highlights the identified strate-
gic areas.
In line with its organisational mandate (research, norms
and standards, support for implementation, monitoring
and evaluation),25 six strategic areas have been identified
for WHO to contribute to ending preventable mortality
and morbidity among mothers and newborns. The QoC
definition and framework will inform this evidence-based
and systematic approach to (1) research, (2) guideline
development, (3) standards of care, (4) identification of
effective intervention strategies for quality improvement,
(5) development of monitoring indicators at global,
national and facility levels, and (6) capacity strengthening
for quality improvement research, measurement and pro-
gramming. Work in these strategic areas will support the
maternal and newborn QoC improvement strategy and
ensure implementation based on robust data, while includ-
ing targeted country-level capacity strengthening and tech-
nical support.
Given the progress made in MDG-4 and MDG-5 in the
past 15 years, with increases in coverage of skilled atten-
dance and essential intervention, the next phase should, in
addition, target multiple domains of quality of care to
Figure 1. WHO Quality of Care Framework for maternal and newborn health.
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reduce further the burden of preventable mortality and
morbidity, integrated as part of the Global Strategy for
Women’s, Children’s and Adolescents’ Health.
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Common sense about prosecutions
for female genital mutilation
prevails—at least for now
DAVID RICHMOND, PRESIDENT, ROYAL COLLEGE OF OBSTETRICIANS AND
GYNAECOLOGISTS, UK..................................................................................................................................................................
On 4 February 2015, Dr DhanusonDharmasena, a Specialist Registrar in
Obstetrics and Gynaecology, was found
not guilty of performing female genital
mutilation (FGM) on a woman shortly
after she gave birth at the Whittington
Hospital in London. His trial was the first
UK prosecution for FGM and received
widespread international attention.
Dr Dharmasena met his patient, A.B.,
for the first time when she was in
advanced labour with a fetal bradycar-
dia. She had undergone major (Type 3)
FGM in Somalia as a child and required
deinfibulation before pregnancy to open
the vagina. Dr Dharmasena performed
a vacuum extraction and delivered a
healthy boy. To facilitate delivery, a 1.5-
cm anterior incision was made through
a small band of scar tissue obscuring
the urethra and preventing catheterisa-
tion. Because this was bleeding postde-
livery, a single figure-of-eight suture was
placed through the skin edge at the
apex. This formed the prosecution’s
case that FGM was performed.
Dr Dharmasena behaved with dignity
and courage throughout his trial. The
speed of the verdict (5 minutes) is
testimony to his integrity and to the
commitment of his legal team led by
Zoe Johnson, QC. Most of all, common
sense prevailed, with the jury deciding
that this was not FGM.
It is unclear why this case was brought
to court but there were discussions
between the Crown Prosecution Service
(CPS), expert witnesses and informally
with clinicians at the hospital. Since the
verdict was announced, Alison Saunders,
the Director of Public Prosecutions, has
agreed to work closely with the Royal
College of Obstetricians and Gynaecolo-
gists (RCOG), a significant and positive
step forward. This case involved preg-
nancy, and there needs to be more
focus on the prevention of the primary
mutilation. Clarity is needed about the
appropriate surgical procedures to cor-
rect trauma, and care for women with
FGM generally needs improvement.
Dr Dharmasena no longer faces a poten-
tial 14-year prison sentence but still
awaits General Medical Council review.
As his management of A.B. was
described in court as ‘exemplary’, it is
hoped this will be speedily resolved. His
clinical record is otherwise unblemished
and he should be encouraged to con-
tinue his training in O&G.
There will be more lessons to be learnt
from this case. Obstetricians are now
uneasy about managing perineal trauma
in this vulnerable group of women, thus
potentially damaging patient care. At a
broader level, there are unresolved issues
around whether female genital cosmetic
surgery (FGCS) constitutes FGM.
However, the law is clear. FGM is child
abuse, a severe form of violence against
women and girls, and illegal. All mater-
nity units should have appropriate gov-
ernance arrangements. Early
identification and intervention are fun-
damental to ensuring that women are
cared for appropriately. The RCOG
and its FGM Task Force are committed
to ensuring that information for trainees
in managing FGM and guidance will be
issued shortly. Furthermore, the RCOG
will work with the CPS to ensure that
future prosecutions for FGM are direc-
ted against perpetrators of FGM and
not doctors caring for the victims.
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